Abstract | BACKGROUND:
Oral lichen planus (OLP) is a relatively common, chronic inflammatory condition, which frequently presents with symptoms of pain and irritation. OLP is often difficult to manage. Therefore there is a need for more effective and safer therapies for symptomatic OLP. OBJECTIVE: Our purpose was to determine the effectiveness of topical tacrolimus as therapy for symptomatic OLP. METHODS: A retrospective review was performed of 13 patients with symptomatic OLP treated with topical tacrolimus between September 1999 and September 2000. RESULTS: Eleven of the 13 patients reported definite symptomatic response to treatment and 2 had no response. Eight patients had a partial response, whereas 3 patients had a complete response with respect to lesion clearance. Seven of the responding patients had no flares with continued treatment. The other 4 patients noted flares soon after stopping the treatment. Side effects were rare and minor. CONCLUSIONS: In this retrospective case series of 13 patients, topical tacrolimus was well tolerated and appeared to be an effective therapy to control symptoms and clear lesions of OLP.
|
Authors | Todd W Rozycki, Roy S Rogers 3rd, Mark R Pittelkow, Marian T McEvoy, Rokea A el-Azhary, Alison J Bruce, Joseph P Fiore, Mark D P Davis |
Journal | Journal of the American Academy of Dermatology
(J Am Acad Dermatol)
Vol. 46
Issue 1
Pg. 27-34
(Jan 2002)
ISSN: 0190-9622 [Print] United States |
PMID | 11756942
(Publication Type: Evaluation Study, Journal Article)
|
Chemical References |
- Anti-Bacterial Agents
- Immunosuppressive Agents
- Tacrolimus
|
Topics |
- Administration, Cutaneous
- Adult
- Aged
- Aged, 80 and over
- Anti-Bacterial Agents
(administration & dosage, therapeutic use)
- Female
- Humans
- Immunosuppressive Agents
(administration & dosage, therapeutic use)
- Lichen Planus, Oral
(drug therapy, pathology)
- Male
- Medical Records
- Middle Aged
- Retrospective Studies
- Tacrolimus
(administration & dosage, therapeutic use)
- Treatment Outcome
|